Granulocyte-macrophage colony-stimulating factor - BioTransplant

Drug Profile

Granulocyte-macrophage colony-stimulating factor - BioTransplant

Alternative Names: GM-CSF - BioTransplant; Porcine GM-CSF; Porcine GM-CSF - BioTransplant

Latest Information Update: 12 Mar 2004

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator BioTransplant (CEASED)
  • Class
  • Mechanism of Action Granulocyte macrophage colony stimulating factor agonists; Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Xenotransplant rejection

Most Recent Events

  • 12 Mar 2004 It appears that BioTransplant has ceased operations
  • 28 Nov 2003 BioTransplant expects to file with the Banruptcy Court in the coming weeks
  • 28 Feb 2003 BioTransplant and Eligix have filed voluntary Chapter 11 petitions
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top